pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 12·1 min read
save

Iran war disruptions begin to emerge upstream of the pharma supply chain

As the Iran war enters its third month, its knock-on effects on raw materials, energy costs and shipping are beginning to be felt in the pharma industry. While the Middle East is barely a player ...

May 12, 2026·read at Endpoints ↗

An oil tanker sits at anchor in the Strait of Hormuz off Bandar Abbas, Iran, on May 2, 2026. (Amirhosein Khorgooi/ISNA via AP) May 12, 2026 01:04 PM EDTUpdated 01:33 PM PharmaManufacturing Iran war dis­rup­tions be­gin to emerge up­stream of the phar­ma sup­ply chain Anna Brown News Reporter As the Iran war en­ters its third month, its knock-on ef­fects on raw ma­te­ri­als, en­er­gy costs and ship­ping are be­gin­ning to be felt in the … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
108 words · retrieved May 12
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
ALS

related stories

  • Jul 9GSK ends brain drug alliance with AlectorBioPharma Dive
  • Jul 9Ipsen succeeds in migraine trials; Tarsus buys iRenix for $75M upfrontEndpoints
  • Jul 7Compass Pathways touts durability data for psilocybin drug in depression ahead of year-end filingEndpoints
  • Jul 7Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trialsEndpoints
  • Jul 6Gene editing developer Scribe plots an IPOBioPharma Dive